MOHS Analytics has acquired majority ownership of Remed Pharmaceuticals, Inc., a research and development driven company as part of its strategy to vertically integrate its flagship healthcare and wellness business.
Remed owns established brands in four pharmaceutical categories—Vitacare, Respicare, Pediacare and Gastrocare with over 20 brands in its portfolio. These products are distributed through 4,500 outlets in major national and regional drugstores and pharmacy chains.
Founded 22 years ago by pharmaceutical industry pillar Remedios Rivera, Remed has grown to leadership position in some of the pharmaceutical categories it is present in.
The company is poised to introduce five more brands in the coming months.
This acquisition follows MOHS’s purchase early this year of a controlling stake in Zenfro Corp., a distribution company with a strong and expanding network in South Greater Manila Area handling top food, beverage, home and personal care products.
MOHS said the acquisitions are in line with its five-year road map to grow into one of the major fully integrated health and wellness companies in the Philippines.
MOHS was among the first to bring in affordable test kits and equipment at the start of the COVID-19 pandemic. It then offered affordable point of care and home test kits for the early detection of diseases such as urinary tract infection, dengue and malaria.
MOHS has also diversified into healthcare software and technologies and point of care innovative systems.
“Vertical integration of our health care business allows MOHS to better control costs to make our products more affordable and our business more sustainable,” said Michael Hortaleza, MOHS chairman and chief executive officer . “Our acquisitions this year follow our strategy of engaging in businesses that add value to Philippine society, by making a wide range of affordable health care products accessible to Filipinos nationwide.
Rivera, Remed chairman and president, said the company can tap MOHS’s distribution expertise in channels it is not currently accessing, while MOHS can tap Remed’s field marketing force to push its health and wellness products to medical professionals.
